Maa: Taiwan
Kieli: kiina
Lähde: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
MOMETASONE FUROATE
百德健有限公司 臺北市中山區民生東路一段58號11樓 (28843592)
D07AC13
乳膏劑
MOMETASONE FUROATE (6804002310) MG
鋁管裝
製 劑
須由醫師處方使用
DONGKOO BIO & PHARMA. CO., LTD. 18, JEYAKGONGDAN 2-GIL, HYANGNAM-EUP, HWASEONG-SI, GYEONGGI-DO, KOREA KR
mometasone
對類固醇具有感受性之皮膚病所引起之炎性反應及搔癢之緩解。
註銷日期: 2022/07/11; 註銷理由: 許可證已逾有效期; 有效日期: 2020/11/09; 英文品名: DERMOTASONE cream
已註銷
2005-11-09
DERMOTASONE CREAM 【 APPEARANCE 】 White cream 【 COMPOSITION 】 One gram contains : Mometasone Furoate -------------------------------------1.0mg 【 INDICATION 】 Relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. 【 DOSAGE AND ADMINISTRATION 】 1. Apply a thin film of Dermotasone Cream 0.1% to the affected skin areas once daily. 2. Dermotasone cream 0.1% should not be used with occlusive dressings unless directed by a physician. 【 CAUTION 】 1. Contra indications 1) Patients who have skin infectious diseases; bacteria (tuberculosis, syphilis, etc), fungus (candida, dermatophyte), virus (herpes zoster, herpes simplex, chickenpox, vaccinia, etc), animal (scabies, phthiriasis pubis, etc). 2) Patients who have been experienced hypersensitivity for this medicine’s ingredients. 3) Eczematous external otitis patients who have drum membrane perforation. 4) Patients who have ulcer, burn more than second degree or chilblain. 5) Perioral dermatitis, general acne, rosacera patients. 6) Patients suffering from perianal and genital pruritis. 7) Baby under the age of 2 years. 2. General cautions. 1) Do not use this medicine for eczema, dermatitis accompanied with skin infection. But if this medicine must be used in an unavoidable case, treat the symptoms with antibacterial agent (systemic administration), antifungal agent first or consider of combined treatment. 2) Systemic absorption of local corticoids may make adverse HPA axis suppression, cushing’s syndrome, hyperglycemia, glucosuria, etc to some patients and the patients treated under wide ranged body surface or ODT with local corticoids shall be periodically checked about HPA axis suppression by plasma cortisol concentrations, measuring cortisol released from urea or ACTH stimulus test. 3) If HPA axis is restrained by systemic absorption of local corticoid, stop using medication, reduce the frequency of administration, and replace to weak activity corticoid. Generally, hypothalamic pituitary adrenal axis functi Lue koko asiakirja